SC 13G/A | 2015-02-17 | SOFINNOVA VENTURE PARTNERS V LP | KALOBIOS PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2015-02-17 | Flynn James E | KALOBIOS PHARMACEUTICALS INC | 2,286,783 | 6.9% | EDGAR |
SC 13G/A | 2015-02-13 | FMR LLC | KALOBIOS PHARMACEUTICALS INC | 1,576,666 | 4.8% | EDGAR |
SC 13G/A | 2015-02-13 | PRIMECAP MANAGEMENT CO/CA/ | KALOBIOS PHARMACEUTICALS INC | 4,475,700 | 13.6% | EDGAR |
SC 13G/A | 2015-02-06 | Vanguard Investment Series PLC | KALOBIOS PHARMACEUTICALS INC | 2,458,500 | 7.4% | EDGAR |
SC 13G/A | 2015-02-05 | MPM BIOVENTURES III L.P. | KALOBIOS PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G | 2015-01-29 | First Eagle Investment Management, LLC | KALOBIOS PHARMACEUTICALS INC | 1,746,591 | 5.3% | EDGAR |
SC 13G/A | 2014-03-10 | FMR LLC | KALOBIOS PHARMACEUTICALS INC | 1,678,366 | 5.1% | EDGAR |
SC 13G/A | 2014-02-14 | FMR LLC | KALOBIOS PHARMACEUTICALS INC | 3,426,712 | 10.4% | EDGAR |
SC 13G/A | 2014-02-14 | PRIMECAP MANAGEMENT CO/CA/ | KALOBIOS PHARMACEUTICALS INC | 4,699,975 | 14.3% | EDGAR |
SC 13G | 2014-02-14 | Alloy Ventures 2000, L.P. | KALOBIOS PHARMACEUTICALS INC | 1,691,694 | 5.1% | EDGAR |
SC 13G/A | 2014-02-13 | BAXTER INTERNATIONAL INC | KALOBIOS PHARMACEUTICALS INC | 958,583 | 2.9% | EDGAR |
SC 13G | 2014-02-13 | MPM BIOVENTURES III L.P. | KALOBIOS PHARMACEUTICALS INC | 129,865 | 0.4% | EDGAR |
SC 13G/A | 2014-02-12 | Vanguard Investment Series PLC | KALOBIOS PHARMACEUTICALS INC | 2,486,375 | 7.6% | EDGAR |
SC 13G | 2014-02-12 | SOFINNOVA VENTURE PARTNERS V LP | KALOBIOS PHARMACEUTICALS INC | 2,072,914 | 8.5% | EDGAR |
SC 13G/A | 2014-02-06 | DEVELOPMENT BANK OF JAPAN INC. | KALOBIOS PHARMACEUTICALS INC | 491,530 | 1.5% | EDGAR |
SC 13G | 2014-02-05 | Flynn James E | KALOBIOS PHARMACEUTICALS INC | 3,175,283 | 9.6% | EDGAR |
SC 13G | 2013-02-14 | Lehman Brothers Holdings Inc. | KALOBIOS PHARMACEUTICALS INC | 1,067,059 | 4.4% | EDGAR |
SC 13G | 2013-02-13 | BAXTER INTERNATIONAL INC | KALOBIOS PHARMACEUTICALS INC | 3,000,308 | 28.0% | EDGAR |
SC 13G | 2013-02-11 | FMR LLC | KALOBIOS PHARMACEUTICALS INC | 3,036,415 | 13.0% | EDGAR |